Picture of Symrise AG logo

SY1 — Symrise AG News Story

0.000.00%
de flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapHigh Flyer

Germany's Symrise H1 organic sales rise 2%, outlook reaffirmed

Germany's Symrise H1 organic sales rise 2%, outlook reaffirmed


Overview

  • Germany flavors and fragrances supplier's H1 organic sales grew 2.0%, with Q2 momentum accelerating

  • Adjusted EBITDA margin for H1 was 21.8%, supported by profitable sales growth and efficiency measures

  • Company reaffirmed full-year 2026 outlook and announced planned acquisition of Floral Concept


Outlook

  • Symrise expects 2026 organic sales growth of 2% to 4%

  • Company sees 2026 adjusted EBITDA margin of 21.5% to 22.5%

  • Symrise expects 2026 adjusted Business Free Cash Flow margin above 14%


Result Drivers

  • FOOD & BEVERAGE, CONSUMER FRAGRANCE, AROMA MOLECULES - Co said Q2 organic sales growth was driven by strong demand in these divisions, especially in North America and Asia Pacific

  • EFFICIENCY MEASURES - Profitable sales growth and efficiency measures supported earnings development, partially offset by transformation investments and logistics costs

  • AROMA MOLECULES GROWTH - High-single-digit organic sales growth in Aroma Molecules, driven by double-digit growth in Specialty Fragrance Ingredients and Menthol


Company press release: ID:nEQ6Xp0Mva


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

EUR 2.54 bln

H1 Organic Growth

2.00%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Symrise AG is €95.25, about 6.9% above its July 29 closing price of €89.08

  • The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 18 three months ago


Reuters Recommended Reads

  • July 30 - Belgium's Azelis H1 revenue rises 3.2% in constant currency

  • July 28 - UK's Croda H1 sales rise on Consumer Care growth

  • July 30 - Germany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Symrise AG

See all news